Lantern Pharma, Inc. LTRN
NASDAQ · United States · Health Technology
$0.9840-0.02 (-1.60%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-14 | -0.57 | -0.38 | -50.0% | $0 | — | -1.1%$2.63→$2.60 |
| Q1 2026 | 2026-05-15 | -0.30 | -0.36 | +16.7% | — | — | -4.2%$3.13→$3.00 |
| Q4 2025 | 2026-03-30 | -0.36 | -0.46 | +21.7% | — | — | +22.3%$1.12→$1.37 |
| Q3 2025 | 2025-11-12 | -0.39 | -0.47 | +17.0% | — | — | -2.3%$3.54→$3.46 |
| Q2 2025 | 2025-08-13 | -0.40 | -0.48 | +16.7% | — | — | — |
| Q1 2025 | 2025-05-15 | -0.42 | -0.49 | +14.3% | — | — | — |
| Q4 2024 | 2025-03-27 | -0.54 | -0.51 | -5.9% | — | — | — |
| Q1 2024 | 2024-05-09 | -0.51 | -0.43 | -18.6% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.